[go: up one dir, main page]

NO20055243L - Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS) - Google Patents

Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS)

Info

Publication number
NO20055243L
NO20055243L NO20055243A NO20055243A NO20055243L NO 20055243 L NO20055243 L NO 20055243L NO 20055243 A NO20055243 A NO 20055243A NO 20055243 A NO20055243 A NO 20055243A NO 20055243 L NO20055243 L NO 20055243L
Authority
NO
Norway
Prior art keywords
sars
acute respiratory
respiratory syndrome
severe acute
interferon beta
Prior art date
Application number
NO20055243A
Other languages
English (en)
Inventor
Giampiero De Luca
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20055243L publication Critical patent/NO20055243L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Anvendelse av et interferon (IFN) til fremstilling av et legemiddel som er nyttig for behandling og/eller forhindring av alvorlig akutt respiratorisk syndrom (SÅRS) er beskrevet i den foreliggende oppfirmelse.
NO20055243A 2003-04-17 2005-11-08 Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS) NO20055243L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03101066 2003-04-17
PCT/EP2004/050456 WO2004091653A1 (en) 2003-04-17 2004-04-06 Interferon beta in severe acute respiratory syndrome (sars)

Publications (1)

Publication Number Publication Date
NO20055243L true NO20055243L (no) 2005-11-08

Family

ID=33185950

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055243A NO20055243L (no) 2003-04-17 2005-11-08 Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS)

Country Status (13)

Country Link
US (1) US20070026014A1 (no)
EP (1) EP1613342A1 (no)
JP (1) JP2006523655A (no)
KR (1) KR20050112127A (no)
CN (1) CN1798572A (no)
AU (1) AU2004229185A1 (no)
BR (1) BRPI0409484A (no)
CA (1) CA2521650A1 (no)
EA (1) EA008766B1 (no)
MX (1) MXPA05011170A (no)
NO (1) NO20055243L (no)
UA (1) UA81481C2 (no)
WO (1) WO2004091653A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006528679A (ja) * 2003-04-01 2006-12-21 インターミューン インコーポレイテッド コロナウイルス感染症及びサースを治療するための組成物及び方法
EP1641485A4 (en) * 2003-06-09 2009-06-24 Genome Inst Of Singapore INHIBITION OF SARS CORONAVIRUS INFECTION USING ANTIVIRAL DRUGS CLINICALLY TESTED
US9295669B2 (en) 2010-12-14 2016-03-29 Hoffman La-Roche Inc. Combination therapy for proliferative disorders
CN115867288A (zh) * 2020-03-27 2023-03-28 维克多瑞有限公司 用于治疗呼吸系统病症的组合物
US20220125661A1 (en) * 2020-10-22 2022-04-28 Jacob Waterman Patient-Worn Therapeutic Apparatus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
BR9910505A (pt) * 1998-05-15 2001-01-02 Schering Corp Terapia de combinação compreendendo ribavirina e interferon alfa em pacientes cândidos de tratamento antiviral tendo infecção crÈnica por hepatite c
JP2002220343A (ja) * 2001-01-26 2002-08-09 Toray Ind Inc びまん性肺疾患延命剤
US20030143199A1 (en) * 2001-10-09 2003-07-31 Carson Dennis A. Use of STAT-6 inhibitors as therapeutic agents
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections
WO2005009337A2 (en) * 2003-05-16 2005-02-03 Hemispherx Biopharma Treating severe acute respiratory syndrome

Also Published As

Publication number Publication date
CN1798572A (zh) 2006-07-05
EP1613342A1 (en) 2006-01-11
EA200501625A1 (ru) 2006-04-28
KR20050112127A (ko) 2005-11-29
WO2004091653A1 (en) 2004-10-28
JP2006523655A (ja) 2006-10-19
AU2004229185A1 (en) 2004-10-28
BRPI0409484A (pt) 2006-05-02
US20070026014A1 (en) 2007-02-01
UA81481C2 (en) 2008-01-10
MXPA05011170A (es) 2005-12-14
CA2521650A1 (en) 2004-10-28
EA008766B1 (ru) 2007-08-31

Similar Documents

Publication Publication Date Title
EE05065B1 (et) Karbamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid
NO20073632L (no) Behandling av hepatitt C med interferon-beta i en asiatisk populasjon
NO20006328D0 (no) Attenuerte negative trådvirus med endret interferonantagonistaktivitet for anvendelse som vaksiner og medikamenter
WO2005023290A3 (en) Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections
ATE476983T1 (de) Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen der atemwege
IL171972A0 (en) Compositions and methods for treatment of severe acute respiratory syndrome(sars)
BR0011433B1 (pt) Compostos de imidazoquinolinas substituídas com sulfonamida e sulfamida e composição farmaceutica cotendo os mesmos
NO20061912L (no) Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system
PL371736A1 (en) Method for administering glp-1 molecules
TW200733953A (en) Materials and methods for treating viral infections
NO20044272L (no) Legemiddel for behandling og/eller forebyggelse av kronisk avstotning
WO2005007078A3 (en) Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (sars)
DK1423168T3 (da) Farmaceutisk præparat omfattende gabapentin eller en analog deraf og et alfa-aminoamid og dets analgetiske anvendelse
EP0652011A4 (en) PROPHYLACTIC MEDICINE AND MEDICINAL PRODUCT FOR VIRAL DISEASES OF THE BREATHWAYS.
NO20065860L (no) Stabiliserte flytende interferonformuleringer
EP1649053A4 (en) CHARACTERIZATION OF THE EARLY LEVELS OF THE VIRUS OF HEAVY ACUTE RESPIRATORY SYNDROME (SARS) AND USES THEREOF
TW200633995A (en) Andrographolide derivatives to treat viral infections
WO2004089983A3 (en) Severe acute respiratory syndrome (sars) causing coronavirus
NO20055243L (no) Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS)
WO2022099187A3 (en) Sars-cov-2 antigen-binding proteins and uses thereof
BR9916893A (pt) Tratamento
NO20053348L (no) Farmasoytisk sammensetning for behandling av virusangrep.
WO2007057436A3 (en) Interferon in influenza
NO20055512L (no) Terapi eller prevensjon av respiratoriske, virale infeksjoner med alfa-tyimosinpeptider
AU2003298578A1 (en) Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application